This analysis for the Peterson-KFF Health System Tracker illustrates the potential for employer savings if the age of Medicare eligibility were lowered to 60, as proposed by President Biden during the 2020 campaign.
- view as grid
- view as list
This brief examines how leading federal and state policy options related to changes in Medicaid Drug Rebate Program (MDRP), drug pricing, and payment and management of the Medicaid prescription drug would affect state and federal governments as well as private industry (including drug manufacturers, managed care organizations, and pharmacies).
On April 15th, the Department of Health and Human Services (HHS) published proposed regulations for the Title X federal family planning program to replace the Trump Administration’s rules, which prohibited abortion referrals and co-located abortion services. The Biden Administration proposes to largely re-instate the Title X regulations that were in…
This collection provides data on COVID-19 vaccine distribution and prioritization, flu and pneumonia vaccination rates, and state policies on vaccine requirements. Create a Custom State Report Use this page to start a custom report compiling data related to COVID-19 for a single state or multiple states. Step 1: Choose from…
This issue brief summarizes findings from 404 studies of the impact of state Medicaid expansions under the ACA published between January 2014 (when the coverage provisions of the ACA went into effect) and January 2020. It includes studies, analyses, and reports published by government, research, and policy organizations using data from 2014 or later. This body of research suggests that the expansion presents an opportunity for gains in coverage, improvements in access and financial security, and economic benefits for states and providers.
Building on the Evidence Base: Studies on the Effects of Medicaid Expansion, February 2020 to March 2021
This report summarizes evidence from nearly 200 studies on the effects of Medicaid expansion published between February 2020 and March 2021. These studies generally find beneficial impacts of expansion across a range of areas.
This fact sheet provides an overview of the history of the Kemp-Kasten amendment, which states that no U.S. funds may be made available to “any organization or program which, as determined by the president of the United States, supports or participates in the management of a program of coercive abortion or involuntary sterilization,” and examines its current application. Since enacted in 1985, Kemp-Kasten has often been used to withhold funding from the United Nations Population Fund (UNFPA).
This issue brief provides a deeper look at telecontraception platforms, offering insights into the practices of 13 different companies that have attempted to make contraception more accessible outside of a clinical setting.
Health care is a top issue for voters in the 2020 election. To understand the health care landscape in which the 2020 election policy debates will unfold, these state health care snapshots provide data across a variety of health policy subjects, including health care costs, health coverage—Medicaid, Medicare, private insurance—and the uninsured, women’s health, health status, and access to care.
This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.